Skip to main content
In stock|Targeted Therapy (Antibody)

Matuzumab

Oncology TypeSolid Tumour
Drug Class / MechanismAnti-EGFR mAb
No Image
Description

Matuzumab is classified as an Anti-EGFR mAb, sourced for use within our Targeted Therapy (Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Antibody)
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3